| PERIOD ENDING | 28-Feb-09 | 29-Feb-08 | 28-Feb-07 | | Total Revenue | 28,539 | 31,878 | 31,573 | | Cost of Revenue | 16,796 | 18,177 | 17,559 | | | Gross Profit | 11,743 | 13,701 | 14,015 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 5,166 | 5,004 | 5,579 | | Non Recurring |
-
|
-
|
-
| | Others | 758 | 783 | 874 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 5,819 | 7,914 | 7,561 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 21 | 102 | 67 | | Earnings Before Interest And Taxes | 5,840 | 8,017 | 7,628 | | Interest Expense | 16 | 2 |
-
| | Income Before Tax | 5,825 | 8,015 | 7,628 | | Income Tax Expense | 2,106 | 3,054 | 2,884 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,719 | 4,961 | 4,745 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 3,719 | 4,961 | 4,745 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,719 | $4,961 | $4,745 |
|
0.34% Nasdaq 
0.11 (1.26%) 
Income Statement
